Biopharma News
Biopharma news
-
News Report Highlights Importance of Communication for Pharma-biotech Deals
Open and frequent communication is vitally important for the success of partnerships between pharmaceutical and biotech companies. -
News Teralys Capital And Eli Lilly And Others Invest in Life Sciences Fund
Teralys Capital and Eli Lilly and Company have invested in a new $150m life sciences fund. -
News French Biotech Sector 'Faces Challenge to Raise Funding'
France Biotech and Ernst & Young's latest report looks at the state of the French biotech industry. -
News Better Risk Assessment Tools Needed for Biopharma Stakeholders
The latest report from biopharmaceutical services company Quintiles has looked at the subject of drug development risk. -
News Biopharma Firms That Secure Corporate Venture Investment 'More Likely to Be Acquired'
Corporate venture funding is a good predictor for licensing deals, acquisition and IPOs, an analysis has revealed. -
News Countries around the World 'Investing in Biopharma'
A report suggests that America's biopharmaceutical dominance could be under threat as countries around the world are investing in the sector. -
News Kythera Biopharmaceuticals Announces Plans to Go Public
Drug developer Kythera Biopharmaceuticals is to go public in a bid to generate funds for its ongoing clinical development of aesthetic medicine ATX-101. -
News Small Biotech Companies to Benefit from Changes to US Patent System
Biotechnology companies - particularly smaller outfits - should benefit from the new patent system being brought in under the America Invents Act. -
News BMS & Tsinghua University Announce New Strategic Partnership
A new collaboration has been announced between Bristol-Myers Squibb and China's Tsinghua University. -
News Orexigen to Be Added to NASDAQ Biotechnology Index
Biopharmaceutical firm Orexigen Therapeutics will be added to the NASDAQ Biotechnology Index effective Monday, May 21, 2012. -
News India Could Become Biopharma Innovation Hub, Report Suggests
A report has highlighted India's potential in the biopharmaceutical industry. -
News Antisense Pharma Announces New CEO
Antisense Pharma has announced the appointment of Dr. Philippe Calais as CEO. -
News Caisson Biotech & Novo Nordisk Enter Development & License Agreement
Novo Nordisk will use Caisson's proprietary drug delivery technology to engineer and develop novel therapeutics. -
News Mucosis Announces Publication of Preclinical Data
Mucosis has announced the publication of preclinical data showing that FluGEM provides superior cross-protection against influenza virus. -
News Horizon Discovery and H3 Biomedicine Announce Oncology Collaboration
Horizon Discovery and biopharmaceutical company H3 Biomedicine have announced a new collaboration agreement. -
News Report Predicts Growth in Single-use Bioreactors Market
A report by Visiongain claims that disposable bioreactor technologies will become more widely used over the coming decade. -
News Nearly 300 Vaccines Being Developed by US Biopharma
A report reveals that there are nearly 300 vaccines in clinical testing or under FDA review at the current time in the US. -
News Ipsen Confirms Commitment to US Growth with Opening of New Commercial HQ
Ipsen has opened its new commercial headquarters in Basking Ridge, New Jersey. -
News Ventria Bioscience acquires Meristem Therapeutics' recombinant lactoferrin IP
Ventria Bioscience is acquiring exclusive ownership rights to intellectual property relating to Meristem Therapeutics' recombinant human lactoferrin.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance